✦ LIBER ✦

PSR1 COST-EFFECTIVENESS OF CLOPIDOGREL VERSUS ASPIRIN IN THE PREVENTION OF ISCHEMIC EVENTS IN STROKE AND TIA PATIENTS: A FOUR-EUROPEAN COUNTRY ANALYSIS

✍ Scribed by AJ Palmer; S Roze; G Hankey; Z Hakimi; J Spiesser; P Carita; S Gabriel

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

PCV44 COST EFFECTIVENESS OF CLOPIDOGREL

✍ BM Yang; S Shin; JH Lee 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB

PCV78 A Cost-Effectiveness Analysis of C

✍ G. Kourlaba; V. Fragoulakis; N. Maniadakis 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 57 KB

PCV33 A COST-EFFECTIVENESS ANALYSIS OF L

✍ M Lamotte; L Annemans; T Evers; M Kubin 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 80 KB

PCV19 EFFECTIVENESS OF ANTIHYPERTENSIVE

✍ S Perreault; R Cote; A Dragomir 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB

The efficacy and safety of aspirin plus

✍ Li, Xia; Zhou, Guoyu; Zhou, Xueying; Zhou, Shengnian 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 498 KB

Cost-Effectiveness of Apixaban Versus St

✍ Athanasakis, K.; Arzoumanidou, D.; Karampli, E.; Armelidou, E.; Giovas, P.; Petr 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB